Fig. 3From: Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancera Forest plots for subgroup analyses of progression-free survival. b Forest plots for subgroup analyses of overall survivalBack to article page